Baker McKenzie Switzerland advised Zug Estates Holding on the acquisition of 100% of the shares of Renggli Holding, domiciled in Zug. Renggli Holding is the indirect owner of a real estate portfolio valued at approximately CHF 110
Tags :Matthias Courvoisier
Baker McKenzie, with lawyers from the Swedish and Swiss offices, acted as legal advisor to Skandinaviska Enskilda Banken (SEB) in their role as Issuer Agent of Swedish Depositary Receipts in connection with the spin-off of
Baker McKenzie has advised an investment fund managed by Highbridge Capital Management on a financing transaction for Invacare Corporation. Highbridge as lender and Invacare as borrower entered into an USD 104.5 million senior secured credit agreement
Baker McKenzie has advised Cicor on the exercise of its option to reopen its issuance of mandatory convertible bonds due 2027 in an amount corresponding to CHF 40,188,000 and to sell those bonds to One Equity Partners.
Baker McKenzie has acted for CLSA and other underwriters in connection with Joincare Pharmaceutical Group Industry, on global depositary receipts listing on the SIX Swiss Exchange. This transactions proves that the China-Switzerland Stock Connect has
Baker McKenzie Switzerland, along with lawyers from the London and Amsterdam office, has advised Zur Rose Group on the placement of convertible bonds due 2026 and a capital increase through an accelerated bookbuilding (“ABB“) process. Zur
Baker McKenzie Switzerland, along with other Baker McKenzie offices, advised Feintool International Holding (“Feintool”) on its capital increase by approximately CHF 202 million via a rights offering. UBS acted as sole global coordinator and bookrunner while
KSA Group has taken another important step on the way to the new green building “Dreiklang”, KSA’s new ecological construction project. The KSA Group was able to raise CHF 120 million on the capital market
SEBA Bank (“SEBA”) successfully completes its Series C funding round, raising CHF 110 million through the issuance of participation certificates (non-voting shares). The financing round was co-led by a consortium of specialized blockchain and fintech investors,
Occlutech Holding, a specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of Swedish Depositary Receipts (SDRs) worth SEK 450 million (
